Davis Aaron I. — SEC Form 4 filings

SEC reporting owner CIK 1465914. 13 Form 4 filings on record with FilingPulse; latest filed 2024-11-07.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-01-23 to 2024-11-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tango Therapeutics, Inc. (TNGX)712 legs · 5,172,731 sh · $24,743,2041
Mirati Therapeutics, Inc. (MRTX)214
Rain Oncology Inc. (RAIN)Director13
Tyra Biosciences, Inc. (TYRA)12
iTeos Therapeutics, Inc. (ITOS)Director22

Form 4 filings — Davis Aaron I.

FiledFormIssuerReported transactionsSource
2024-11-074Tango Therapeutics, Inc. (TNGX)
jointly with Boxer Capital Management, LLC
Sale (S): 3,080,000 @ $3.14EDGAR
2024-10-284Tango Therapeutics, Inc. (TNGX)
jointly with Boxer Capital Management, LLC
Sale (S): 633,000 @ $6.87EDGAR
2024-10-234Tango Therapeutics, Inc. (TNGX)
jointly with Boxer Capital Management, LLC
Sale (S): 625,000 @ $7.05 · Sale (S): 250,000 @ $6.78EDGAR
2024-09-054Tango Therapeutics, Inc. (TNGX)Other (J): 65,000 (derivative) @ $0EDGAR
2024-07-024Tango Therapeutics, Inc. (TNGX)
jointly with MVA Investors, LLC
Sale (S): 29,000 @ $8.57 · Sale (S): 110,731 @ $8.87 · Sale (S): 95,000 @ $8.68EDGAR
2024-06-134iTeos Therapeutics, Inc. (ITOS)Grant/award (A): 24,200 (derivative) @ $0EDGAR
2024-06-074Tango Therapeutics, Inc. (TNGX)
jointly with MVA Investors, LLC
Sale (S): 63,000 @ $7.24 · Sale (S): 77,000 @ $6.88EDGAR
2024-05-144iTeos Therapeutics, Inc. (ITOS)
jointly with Boxer Capital, LLC, Boxer Asset Management Inc., LEWIS JOSEPH
Grant/award (A): 1,142,857 @ $17.50EDGAR
2024-05-034Tango Therapeutics, Inc. (TNGX)
jointly with MVA Investors, LLC
Sale (S): 75,000 @ $7.43 · Sale (S): 75,000 @ $7.56 · Sale (S): 60,000 @ $7.61EDGAR
2024-02-084Tyra Biosciences, Inc. (TYRA)
jointly with Boxer Capital, LLC, Boxer Asset Management Inc., LEWIS JOSEPH, MVA Investors, LLC
Grant/award (A): 63,412 @ $13.01 · Grant/award (A): 705,280 (derivative) @ $13.01EDGAR
2024-01-264Rain Oncology Inc. (RAIN)Code (U): 79,726 · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2024-01-254Mirati Therapeutics, Inc. (MRTX)
jointly with Boxer Capital, LLC, Boxer Asset Management Inc., LEWIS JOSEPH, MVA Investors, LLC, Dissanayake Shehan Bharatha, Fuglesang Christopher, Braslyn Ltd., Lockend Five, LLC
Disposition to issuer (D): 287,866 · Disposition to issuer (D): 3,201,440 · Disposition to issuer (D): 203,754 · Disposition to issuer (D): 3,135,966 · Disposition to issuer (D): 30,518 · Disposition to issuer (D): 332,809 (derivative) · +2 moreEDGAR
2024-01-234Mirati Therapeutics, Inc. (MRTX)Disposition to issuer (D): 43,073 · Disposition to issuer (D): 4,444 · Disposition to issuer (D): 6,808 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 7,520 (derivative) · Disposition to issuer (D): 11,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1465914 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →